US 7404956
Immunoglobulin chimeric monomer-dimer hybrids
granted A61KA61K38/00A61K47/60
Quick answer
US patent 7404956 (Immunoglobulin chimeric monomer-dimer hybrids) held by Syntonix Pharmaceuticals, Inc. expires Mon Jul 24 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Syntonix Pharmaceuticals, Inc.
- Grant date
- Tue Jul 29 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 24 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 48
- CPC classes
- A61K, A61K38/00, A61K47/60, A61K47/642, A61K47/68